Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

I totally disagree fatwallit......Revenue in the coffer does not mean a share price will grow. It is what is done by management with the cash that investors speculate on. Example: A company signs a license agreement for X millions and the share price goes down. Why....no faith in management to utilize the cash to grow the company. I know the example is farfetched but I hope you see my point.

teremoto

Share
New Message
Please login to post a reply